24th Porto Cancer Meeting 2017
Liquid biopsy: bringing precision medicine closer to oncology

Brian Dougherty
AstraZeneca Oncology IMED Translational Science Group, USA

Brian Dougherty is a Senior Principal Scientist in the AstraZeneca Oncology IMED Translational Science group in Boston, MA. He oversees a team of lab scientists and computational biologists applying leading-edge genetic, genomic, and advanced algorithmic technologies to deliver on Precision Medicine – matching the right patient with the right drug. In 2015, Brian received the AstraZeneca CEO Award and the IMED Science Team Award. He works on cross-functional teams that bring new therapies to cancer patients such as for ovarian cancer (2014) and Tagrisso for lung cancer (2015).